IBL Healthcare Limited informed Pakistan Stock Exchange that extraordinary general meeting of the company is scheduled to be held on June 03, 2020 at Karachi.

The agenda of the meeting will be confirming the minutes of the annual general meeting held on October 25, 2019 and to elect seven directors of the Company as fixed by the Board of Directors in accordance with section 159 (2) of the Companies Act, 2017 for a term of three years in place of retiring director they are eligible for re-election.

Further, the closed period of the company is from May 28, 2020 to June 03, 2020 (both days inclusive).

The announcement is available at:

https://dps.psx.com.pk/download/document/147761.pdf

The company was incorporated in Pakistan as a private limited company on July 14, 1997. In November 2008 the Company was converted into a public limited company. The foundations of the company are laid under the Companies Ordinance, 1984. The company is a wholly owned subsidiary of Searle Pakistan Limited. The principal business activities of the company are marketing and selling, distribution of healthcare products. The shares of the company are quoted on the Karachi Stock Exchange. The registered office of the company is located in Karachi.

The portfolio of the company includes divided into three distinct categories, namely Nutritional Products, Plasma Protein Components and Hospital Disposables. The company is the major partner of globally recognized multinational organizations having expertise in their respective fields of health care products. The partners of the company include MeadJohnson Nutritionals - USA, Tyco Health Care - USA, Intersurgical - UK, Terumo - Japan and Molnlycke - Sweden.

The symbol "IBLHL" is being used by the stock exchanges for the shares of IBL Healthcare Limited.

© Pakistan Press International, source Asianet-Pakistan